Clinical trial
The Underlying Neural Mechanism of TMS in Improving the Imbalance of "Microbiota-brain-gut Axis" in Alzheimer 's Disease Population
NCT07346794 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Nanchang University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Underlying Neural Mechanism of TMS in Improving the Imbalance of "Microbiota-brain-gut Axis" in Alzheimer 's Disease Population
- Lead sponsor
- Second Affiliated Hospital of Nanchang University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- April 21, 2026
- Completion date
- September 30, 2030
- Enrollment
- 400 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease, rtms stimulation